Subject to Completion. Dated December 27, 2018.
GS Finance Corp.$
Leveraged EURO STOXX 50® Index-Linked Notes due
guaranteed by
The Goldman Sachs Group, Inc.
|
● |
if the index return is positive (the final index level is greater than the initial index level), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) the participation rate times (c) the index return; or
|
● |
if the index return is zero or negative (the final index level is equal to or less than the initial index level), $1,000.
|
Original issue date:
|
expected to be January 31, 2019
|
Original issue price:
|
100% of the face amount*
|
Underwriting discount:
|
% of the face amount*
|
Net proceeds to the issuer:
|
% of the face amount
|
|
Estimated Value of Your Notes
The estimated value of your notes at the time the terms of your notes are set on the trade date (as
determined by reference to pricing models used by Goldman Sachs & Co. LLC (GS&Co.) and taking into account our credit spreads) is expected to be between $880 and $930 per $1,000 face amount, which is less than the original issue price. The value of your notes at any time will
reflect many factors and cannot be predicted; however, the price (not including GS&Co.’s customary bid and ask spreads) at which GS&Co. would initially buy or sell notes (if it makes a market, which it is not obligated to do) and the value that GS&Co. will initially use
for account statements and otherwise is equal to approximately the estimated value of your notes at the time of pricing, plus an additional amount (initially equal to $ per $1,000 face amount).
Prior to , the price (not including GS&Co.’s customary bid and ask spreads) at which
GS&Co. would buy or sell your notes (if it makes a market, which it is not obligated to do) will equal approximately the sum of (a) the then-current estimated value of your notes (as determined by reference to GS&Co.’s pricing
models) plus (b) any remaining additional amount (the additional amount will decline to zero on a straight-line basis from the time of pricing through ). On and after , the price (not including GS&Co.’s customary bid
and ask spreads) at which GS&Co. would buy or sell your notes (if it makes a market) will equal approximately the then-current estimated value of your notes determined by reference to such pricing models.
|
|
|
About Your Prospectus
The notes are part of the Medium-Term Notes, Series E program of GS Finance Corp. and are fully and unconditionally guaranteed by The
Goldman Sachs Group, Inc. This prospectus includes this pricing supplement and the accompanying documents listed below. This pricing supplement constitutes a supplement to the documents listed below and should be read in conjunction
with such documents:
The information in this pricing supplement supersedes any conflicting information in the documents listed above. In addition, some of the
terms or features described in the listed documents may not apply to your notes.
|
|
Leveraged EURO STOXX 50® Index-Linked Notes due
|
||||||
INVESTMENT THESIS
|
● |
For investors willing to forgo interest payments for the potential to earn between 2.1x and 2.25x leveraged upside participation if the underlier return is positive
|
DETERMINING THE CASH SETTLEMENT AMOUNT
|
● |
If the final underlier level is greater than 100% of the initial underlier level, 100% plus between
210% and 225% times the underlier return; or
|
● |
If the final underlier level is equal to or less than the initial underlier level, 100%
|
KEY TERMS
|
|
Issuer:
|
GS Finance Corp.
|
Guarantor:
|
The Goldman Sachs Group, Inc.
|
Underlier:
|
The EURO STOXX 50® Index (Bloomberg symbol, “SX5E Index”)
|
Face Amount:
|
$ in the aggregate; each note will have a face amount equal to $1,000
|
Trade Date:
|
Expected to be January 28, 2019
|
Settlement Date:
|
Expected to be January 31, 2019
|
Determination Date:
|
Expected to be January 28, 2025
|
Stated Maturity Date:
|
Expected to be January 31, 2025
|
Initial Underlier Level:
|
To be determined on the trade date
|
Final Underlier Level:
|
The closing level of the underlier on the determination date
|
Underlier Return:
|
The quotient of (i) the final underlier level minus the initial underlier level divided by (ii) the initial underlier level,
expressed as a positive or negative percentage
|
Upside Participation Rate:
|
Expected to be between 210% and 225%
|
CUSIP/ISIN:
|
40056EPG7 / US40056EPG79
|
HYPOTHETICAL PAYMENT AT MATURITY*
|
Hypothetical Final Underlier
Level (as Percentage of Initial
Underlier Level)
|
Hypothetical Cash Settlement
Amount (as Percentage of Face
Amount)
|
200.000%
|
310.000%
|
175.000%
|
257.500%
|
150.000%
|
205.000%
|
125.000%
|
152.500%
|
100.000%
|
100.000%
|
75.000%
|
100.000%
|
50.000%
|
100.000%
|
25.000%
|
100.000%
|
0.000%
|
100.000%
|
|
RISKS
|
|
We refer to the notes we are offering by this pricing supplement as the “offered notes” or the “notes”. Each of the
offered notes has the terms described below. Please note that in this pricing supplement, references to “GS Finance Corp.”, “we”, “our” and “us” mean only GS Finance Corp. and do not include its subsidiaries or affiliates, references to
“The Goldman Sachs Group, Inc.”, our parent company, mean only The Goldman Sachs Group, Inc. and do not include its subsidiaries or affiliates and references to “Goldman Sachs” mean The Goldman Sachs Group, Inc. together with its
consolidated subsidiaries and affiliates, including us. Also, references to the “accompanying prospectus” mean the accompanying prospectus, dated July 10, 2017, references to the “accompanying prospectus supplement” mean the
accompanying prospectus supplement, dated July 10, 2017, for Medium-Term Notes, Series E, references to the “accompanying general terms supplement no. 1,734” mean the accompanying general terms supplement no. 1,734, dated July 10, 2017,
and references to the “accompanying product supplement no. 1,743” mean the accompanying product supplement no. 1,743, dated July 10, 2017, in each case of GS Finance Corp. and The Goldman Sachs Group, Inc. The notes will be issued under
the senior debt indenture, dated as of October 10, 2008, as supplemented by the First Supplemental Indenture, dated as of February 20, 2015, each among us, as issuer, The Goldman Sachs Group, Inc., as guarantor, and The Bank of New York
Mellon, as trustee. This indenture, as so supplemented and as further supplemented thereafter, is referred to as the “GSFC 2008 indenture” in the accompanying prospectus supplement.
This section is meant as a summary and should be read in conjunction with the section entitled “General Terms of the
Underlier-Linked Notes” on page S-27 of the accompanying product supplement no. 1,743 and “Supplemental Terms of the Notes” on page S-16 of the accompanying general terms supplement no. 1,734. Please note that certain features, as noted
below, described in the accompanying product supplement no. 1,743 and general terms supplement no. 1,734 are not applicable to the notes. This pricing supplement supersedes any conflicting provisions of the accompanying product
supplement no. 1,743 or the accompanying general terms supplement no. 1,734.
|
|
● |
type of notes: notes linked to a single underlier
|
● |
exchange rates: not applicable
|
● |
averaging dates: not applicable
|
● |
redemption right or price dependent redemption right: not applicable
|
● |
cap level: not applicable
|
● |
downside participation percentage: not applicable
|
● |
interest: not applicable
|
● |
if the final underlier level is greater than the initial underlier level, the sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the upside participation rate times (iii) the underlier return; or
|
● |
if the final underlier level is equal to or less than the initial underlier level, $1,000
|
Key Terms and Assumptions
|
|
Face amount
|
$1,000
|
Upside participation rate
|
210%
|
Neither a market disruption event nor a non-trading day occurs on the originally scheduled determination date
|
|
No change in or affecting any of the underlier stocks or the method by which the underlier sponsor calculates the underlier
|
|
Notes purchased on original issue date at the face amount and held to the stated maturity date
|
Hypothetical Final Underlier Level
(as Percentage of Initial Underlier Level)
|
Hypothetical Cash Settlement Amount
(as Percentage of Face Amount)
|
200.000%
|
310.000%
|
175.000%
|
257.500%
|
150.000%
|
205.000%
|
125.000%
|
152.500%
|
100.000%
|
100.000%
|
75.000%
|
100.000%
|
50.000%
|
100.000%
|
25.000%
|
100.000%
|
0.000%
|
100.000%
|
|
We cannot predict the actual final underlier level or what the
market value of your notes will be on any particular trading day, nor can we predict the relationship between the underlier level and the market value of
your notes at any time prior to the stated maturity date. The actual amount that you will receive at maturity and the rate of return on the offered notes will depend on the actual initial underlier level and the upside participation
rate, which we will set on the trade date, and the actual final underlier level determined by the calculation agent as described above. Moreover, the assumptions on which the hypothetical returns are based may turn out to be
inaccurate. Consequently, the amount of cash to be paid in respect of your notes on the stated maturity date may be very different from the information reflected in the examples above.
|
|
|
An investment in your notes is subject to the risks described below,
as well as the risks and considerations described in the accompanying prospectus, in the accompanying prospectus supplement, under “Additional Risk Factors Specific to the Notes” in the accompanying general terms supplement no. 1,734
and under “Additional Risk Factors Specific to the Underlier-Linked Notes” in the accompanying product supplement no. 1,743. You should carefully review these risks and considerations as well as the terms of the notes described
herein and in the accompanying prospectus, the accompanying prospectus supplement, the accompanying general terms supplement no. 1,734 and the accompanying product supplement no. 1,743. Your notes are a riskier investment than
ordinary debt securities. Also, your notes are not equivalent to investing directly in the underlier stocks, i.e., the stocks comprising the underlier to which your notes are linked. You should carefully consider whether the offered
notes are suited to your particular circumstances.
|
|
● |
a dealer in securities or currencies;
|
● |
a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings;
|
● |
a bank;
|
● |
a regulated investment company;
|
● |
a life insurance company;
|
● |
a tax-exempt organization;
|
● |
a partnership;
|
● |
a person that owns the notes as a hedge or that is hedged against interest rate risks;
|
● |
a person that owns the notes as part of a straddle or conversion transaction for tax purposes; or
|
● |
a United States holder (as defined below) whose functional currency for tax purposes is not the U.S. dollar.
|
|
You should consult your tax advisor concerning the U.S. federal income tax and other tax consequences of your
investment in the notes, including the application of state, local or other tax laws and the possible effects of changes in federal or other tax laws.
|
|
● |
a citizen or resident of the United States;
|
● |
a domestic corporation;
|
● |
an estate whose income is subject to U.S. federal income tax regardless of its source; or
|
● |
a trust if a United States court can exercise primary supervision over the trust’s administration and one or more United States persons are authorized to control all substantial
decisions of the trust.
|
Accrual Period
|
Interest Deemed to Accrue
During Accrual Period
(per $1,000 note)
|
Total Interest Deemed to
Have Accrued from
Original Issue Date (per
$1,000 note) as of End of
Accrual Period
|
through December 31, 2019
|
||
January 1, 2020 through December 31, 2020
|
||
January 1, 2021 through December 31, 2021
|
||
January 1, 2022 through December 31, 2022
|
||
January 1, 2023 through December 31, 2023
|
||
January 1, 2024 through December 31, 2024
|
||
January 1, 2025 through
|
The comparable yield and projected payment schedule are not provided to you for any purpose other than the determination of your
interest accruals in respect of your notes, and we make no representation regarding the amount of contingent payments with respect to your notes.
|
● |
a nonresident alien individual;
|
● |
a foreign corporation; or
|
● |
an estate or trust that in either case is not subject to U.S. federal income tax on a net income basis on income or gain from the notes.
|
Page
|
|
PS-5
|
|
PS-8
|
|
PS-11
|
|
PS-14
|
|
PS-16
|
|
Product Supplement No. 1,743 dated July 10, 2017
|
|
Summary Information
|
S-1
|
Hypothetical Returns on the Underlier-Linked Notes
|
S-8
|
Additional Risk Factors Specific to the Underlier-Linked Notes
|
S-23
|
General Terms of the Underlier-Linked Notes
|
S-27
|
Use of Proceeds
|
S-31
|
Hedging
|
S-31
|
Supplemental Discussion of Federal Income Tax Consequences
|
S-33
|
Employee Retirement Income Security Act
|
S-43
|
Supplemental Plan of Distribution
|
S-44
|
Conflicts of Interest
|
S-47
|
General Terms Supplement No. 1,734 dated July 10, 2017
|
|
Additional Risk Factors Specific to the Notes
|
S-1
|
Supplemental Terms of the Notes
|
S-16
|
The Underliers
|
S-36
|
S&P 500® Index
|
S-40
|
MSCI Indices
|
S-46
|
Hang Seng China Enterprises Index
|
S-55
|
Russell 2000® Index
|
S-61
|
FTSE®100 Index
|
S-69
|
EURO STOXX 50® Index
|
S-75
|
TOPIX
|
S-82
|
The Dow Jones Industrial Average®
|
S-87
|
The iShares® MSCI Emerging Markets ETF
|
S-91
|
Use of Proceeds
|
S-94
|
Hedging
|
S-94
|
Employee Retirement Income Security Act
|
S-95
|
Supplemental Plan of Distribution
|
S-96
|
Conflicts of Interest
|
S-98
|
Prospectus Supplement dated July 10, 2017
|
|
Use of Proceeds
|
S-2
|
Description of Notes We May Offer
|
S-3
|
Considerations Relating to Indexed Notes
|
S-15
|
United States Taxation
|
S-18
|
Employee Retirement Income Security Act
|
S-19
|
Supplemental Plan of Distribution
|
S-20
|
Validity of the Notes and Guarantees
|
S-21
|
Prospectus dated July 10, 2017
|
|
Available Information
|
2
|
Prospectus Summary
|
4
|
Risks Relating to Regulatory Resolution Strategies and Long-Term Debt Requirements
|
8
|
Use of Proceeds
|
11
|
Description of Debt Securities We May Offer
|
12
|
Description of Warrants We May Offer
|
45
|
Description of Units We May Offer
|
60
|
GS Finance Corp.
|
65
|
Legal Ownership and Book-Entry Issuance
|
67
|
Considerations Relating to Floating Rate Debt Securities
|
72
|
Considerations Relating to Indexed Securities
|
73
|
Considerations Relating to Securities Denominated or Payable in or Linked to a Non-U.S. Dollar Currency
|
74
|
United States Taxation
|
77
|
Plan of Distribution
|
92
|
Conflicts of Interest
|
94
|
Employee Retirement Income Security Act
|
95
|
Validity of the Securities and Guarantees
|
95
|
Experts
|
96
|
Review of Unaudited Condensed Consolidated Financial Statements by Independent Registered Public Accounting Firm
|
96
|
Cautionary Statement Pursuant to the Private Securities Litigation Reform Act of 1995
|
96
|